A new biotech out of Dana-Far­ber wants to join the long non-cod­ing RNA par­ty, with help from Bob Langer

Biotechs fo­cus­ing on long non-cod­ing RNAs have pro­lif­er­at­ed in re­cent years, and an­oth­er new com­pa­ny an­nounced its launch ear­ly Tues­day.

Nex­tR­NA Ther­a­peu­tics came out of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER